In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
A safety net health care provider has won a $10.3 million interim arbitration judgment against Eagan-based Prime Therapeutics over price-fixing allegations between the local pharmacy benefits manager ...
The Federal Trade Commission on Jan. 14 published a second interim staff report on the prescription drug middleman industry, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback